# Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC

> **NCT05433701** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Jonggi Choi** · enrollment: 178 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy
- **PROCEDURE:** Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT05433701
- **Lead sponsor:** Jonggi Choi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-29
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05433701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05433701, "Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05433701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*